Table 4.
Region | URP85109 | URP84966 | URP85049 | |||
---|---|---|---|---|---|---|
MHC-I Epitopes | MHC-II Epitopes | MHC-I Epitopes | MHC-II Epitopes | MHC-I Epitopes | MHC-II Epitopes | |
World | 100.0% | 83.81% | 100.0% | 83.81% | 100.0% | 83.81% |
East Asia | 100.0% | 82.41% | 100.0% | 82.41% | 100.0% | 82.41% |
Northwest Asia | 98.55% | 60.8% | 98.55% | 60.8% | 98.55% | 60.8% |
South Asia | 100.0% | 76.44% | 100.0% | 76.44% | 100.0% | 76.44% |
Southeast Asia | 100.0% | 58.83% | 100.0% | 58.83% | 100.0% | 58.83% |
Southwest Asia | 98.66% | 45.29% | 98.66% | 45.29% | 98.66% | 45.29% |
Europe | 100.0% | 87.47% | 100.0% | 87.47% | 100.0% | 87.47% |
East Africa | 98.74% | 68.53% | 98.74% | 68.53% | 98.74% | 68.53% |
West Africa | 99.12% | 65.81% | 99.12% | 65.81% | 99.12% | 65.81% |
Central Africa | 98.39% | 62.84% | 98.39% | 62.84% | 98.39% | 62.84% |
North Africa | 99.6% | 76.07% | 99.6% | 76.07% | 99.6% | 76.07% |
South Africa | 99.64% | 32.1% | 99.64% | 32.1% | 99.64% | 32.1% |
West Indies | 99.57% | 70.02% | 99.57% | 70.02% | 99.57% | 70.02% |
North America | 100.0% | 90.03% | 100.0% | 90.03% | 100.0% | 90.03% |
Central America | 9.07% | 53.91% | 9.07% | 53.91% | 9.07% | 53.91% |
South America | 100.0% | 63.52% | 100.0% | 63.52% | 100.0% | 63.52% |
Oceania | 99.15% | 60.21% | 99.15% | 60.21% | 99.15% | 60.21% |